A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma

NCT01891747 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Malignant Glioma

Interventions

DRUG: Bevacizumab
DRUG: Temozolomide
DIETARY_SUPPLEMENT: Vitamin C

Sponsor

Vanderbilt-Ingram Cancer Center